Home / Letter From The Editor / June 27, 2020

June 27, 2020

Jun 27, 2020

Although many of us would have liked to spend a week in Chicago at the ADA Scientific Sessions, the pandemic forced us to miss a chance to have some great food and fun. Although the live session is always good, it was kind of nice to do the sessions at your leisure via the web. One of the best parts was the opportunity to review things and share with others.

There was a study presented that looked at a once a week basal insulin. This grabbed me as a drug I wanted to learn more about, so I gave our intern, Lawand Kamal, PharmD Candidate 2021, Skaggs School of Pharmacy and Pharmaceutical Sciences, the project to teach me about this new insulin.


My thought process was that if this works, you give a patient one shot of insulin and a weekly GLP-1, and without a doubt you have the best 1-2 punch for managing type 2 diabetes. Check out what Lawand taught me by clicking here.


We can make a difference!


Dave Joffe